Table 2 Evaluation of α-klotho, FGF-23, IL-6, TNF-α, PLT and BDNF as potential serum biomarkers for the diagnosis of hemodialysis-induced mild cognitive decline.

From: Differential expression of serum biomarkers in hemodialysis patients with mild cognitive decline: A prospective single-center cohort study

Evaluation index

cut-off value

Sensitivity

Specificity

Positive predictive value

Negative predictive value

Accuracy

α-klotho, (n)

469.5 pg/ml

41.4% (12/29)

44.8% (13/29)

42.9% (12/28)

43.3% (13/30)

43.1% (25/58)

FGF-23, (n)

1264.5 ng/ml

62.1% (18/29)

31.0% (9/29)

64.3% (18/28)

30.0% (9/30)

46.6% (27/58)

IL-6, (n)

1.8 pg/ml

17.2% (5/29)

44.8% (13/29)

17.9% (5/28)

43.3% (13/30)

31.0% (18/58)

TNF-α, (n)

21.1 pg/ml

37.9% (11/29)

10.3% (3/29)

39.3% (11/28)

10.0% (3/30)

24.1% (14/58)

PLT, (n)

158.5 × 109/L

51.7% (15/29)

17.2% (5/29)

38.5% (15/39)

26.3% (5/19)

35.0% (20/58)

BDNF, (n)

20.0 ng/ml

13.8 (4/29)

65.5 (19/29)

28.6 (4/14)

43.2 (19/44)

40.0 (23/58)

  1. BDNF: brain-derived neurotrophic factor; FGF-23: fibroblast growth factor-23; IL-6: interleukin-6; MCD: mild cognitive decline; PLT: platelet; ROC: receiver operating characteristic; TNF-α: tumour necrosis factor-α.